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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of taxation of unprocessed sugar or sugar-added foods in the general population on the:
1. consumption of unprocessed sugar or sugar-added foods;
2. prevalence and incidence of overweight and obesity; and
3. prevalence and incidence of diet-related health conditions.
B A C K G R O U N D
Description of the condition
Preventive action and interventions are urgently needed to curb
the obesity epidemic and its detrimental health impacts (WHO
2000). Overweight and obesity are serious global public health
issues, with increasing prevalences in low-, middle-, and high-in-
come countries (De Onis 2010; James 2004; WHO 2000). Ac-
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cording to the most recent report from the World Health Orga-
nization (WHO) (WHO 2014), the global prevalences of over-
weight (body mass index (BMI) ≥ 25) are 38% for men and
40% for women, and for obesity (BMI ≥ 30), 11% for men and
14% for women. In some African countries, prevalences of over-
weight and obesity are comparatively low at 16% and 3%, respec-
tively, whereas in the Pacific Islands, prevalences for overweight
and obesity are alarming, at up to 81% and 51%, respectively. In
2013, about 42 million children (under 5 years) were estimated
to be overweight. Prevalences of childhood overweight and obe-
sity are growing rapidly, specifically in low- and lower-middle in-
come countries. Overweight and obesity are major risk factors for
morbidity and mortality, accounting for about 3.4 million deaths
per year and 93.6 million disability-adjusted life years (DALYs)
worldwide (WHO 2014). From a global perspective, obesity- and
overweight-associated morbidity and mortality rates are, generally
speaking, lower in middle- and high-income countries than in
low-income countries (Dinsa 2012; Drewnowski 2004; Ng 2014;
Robroek 2013; Salois 2012; Valera 2015; WHO 2009).
Within a country, the distribution of overweight and obesity usu-
ally follows a social gradient, generally with higher prevalences of
overweight and obesity observed in people with a lower socioeco-
nomic status (SES).However, in some low-income countries, such
as Cameroon and many Pacific Island countries and territories,
overweight and obesity are more prevalent in people with a higher
SES. In some low- and middle-income countries (e.g. China), the
relationship of SES with overweight and obesity, respectively, is
unclear (Dinsa 2012; McLaren 2007; Ogden 2015; Wang 2012).
Across the globe, major dietary shifts occur, resulting in nutri-
tional transitions. Nutritional transitions - reflecting changes in
diet, physical activity and health - are major components of the
globally increasing prevalences of overweight and obesity. In the
last four decades, food consumption by calories rose by about 400
calories per person a day on average across the globe. However,
the main sources of calorie intake greatly differ between develop-
ing and industrial countries. In developing countries, calorie con-
sumption increased between 1963 and 2003 for sugar (by 127%),
meat (by 119%), and vegetable oils (by 199%), while in indus-
trial countries, only consumption of vegetable oils increased sub-
stantially (by 105%). In China - a major developing country that
was classified as an upper-middle income country by the World
Bank for the 2016 fiscal year - dramatic nutritional transitions
have been observed over the past four decades, resulting in con-
sumption increases of sugar (by 305%), meat (by 349%), and veg-
etable oils (by 680%) (Kearney 2010; World Bank 2015). How-
ever, inside a country such as China, these changes occur more
rapidly among people with lower incomes (Popkin 2002). Con-
sumption of sugar notably increased in developing countries with
lower incomes, particularly in Asia, Latin America and Africa. In
high-income settings, time trends of sugar consumption show re-
gional differences: thus, some industrialised high-income regions,
such as North America, show declines in sugar intake, whereas
in Europe, consumption of sugar increased modestly (Kearney
2010). The prevalence of obesity and overweight is substantially
higher among indigenous populations (e.g. Aboriginal commu-
nities) than among the rest of the national populations. A major
cause might be excessive consumption of sugar, sugar-sweetened
beverages (SSBs), and white flour among indigenous populations
(Lee 1994). However, across the globe, indigenous populations
underwent an extreme nutritional transition in recent decades.Di-
etary changes include consumption of less traditional foods that
are high in sugar, fat and carbohydrates, and more vitamins, pro-
teins, zinc and magnesium (Kuhnlein 2004). The Third Strategic
Report of the Mediterranean Diet Surveillance System has shown
that European Mediterranean countries underwent a ‘westernisa-
tion’ of nutritional patterns. Consumption of vegetables declined,
but intake of sugar, sweeteners, oil, and meat increased. In con-
trast, countries in Northern Europe transited into healthier nutri-
tional patterns (Vareiro 2009).
Unprocessed sugar and sugar-added foods play a major role in the
causal chain of overweight and obesity. We define unprocessed
sugar for the purpose of this review - on the basis of the definitions
of “sugars” and “free sugars” given below- as monosaccharides
(such as glucose, fructose, and galactose), disaccharides (such as
lactose, maltose, sucrose and honey) and higher saccharides (such
as cellulose).
Traditionally, the term “sugars” describes mono- and disaccharides
(FAO/WHO1998).Monosaccharides include fructose, galactose,
and glucose. Disaccharides include lactose, maltose, sucrose, and
trehalose. Some sweeteners, such as corn syrups, mainly consist
of higher saccharides. In 2002, the Joint WHO and Food and
Agriculture Organization of the United Nations (FAO) Expert
Consultation introduced the term “free sugars” (Amine 2002). In
2015, the term was elaborated for the WHO guideline on sugar
intake for adults and children. “Free sugars” are defined as mono-
and disaccharides (such as lactose, maltose, sucrose and honey)
that are added to foods (WHO 2015a).
We define “sugar-added foods” for the purpose of this review - on
the basis of the following definitions - as non-liquid food products
(i.e. this review does not include drinks) that contain artificially-
added sugar in various quantities, where sugar refers to monosac-
charides (such as glucose, fructose, and galactose), disaccharides
(such as lactose, maltose, sucrose and honey) and higher saccha-
rides (such as cellulose).
Based on the definition of the US Department of Agriculture
(USDA), added sugars are sugars and natural products with higher
contents of sugar, such as honey, that are added to foods during
processing or preparation. In the preparation of a food product,
sugars can be processed in any way, e.g. baked or cooked. Added
sugar mainly appears in cakes, cookies, desserts, pies, and candy.
“Specifically, added sugars include white sugar, brown sugar, raw
sugar, corn syrup, corn-syrup solids, high-fructose corn syrup,
maple syrup, pancake syrup, fructose sweetener, liquid fructose,
honey, molasses, anhydrous dextrose, and crystal dextrose. Added
2Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health
outcomes (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
sugars do not include naturally occurring sugars such as lactose in
milk or fructose in fruits” (USDA/HHS 2000).
Overweight and obesity are defined as an excess of adipose tis-
sue in one’s body - arising from an imbalance between energy in-
take and expenditure - due to diverse genetic, environmental, cul-
tural, behavioral, and economic factors (Kopelman 2007; WHO
2015b). Increased energy intake results from overconsumption
and surplus quantities of high-caloric foods. Unprocessed sugar
and sugar-added foods are a main source of excessive calorie intake
(Bowman 2004; Popkin 2003). Thus, a sugar-rich diet and less
physical activity may cause overweight and obesity, resulting di-
rectly in alterations in blood pressure (e.g. hypertension), dyslip-
idaemia, peripheral insulin resistance, inflammation, and dental
caries (Kopelman 2007; Moynihan 2014; WHO 2015b). These
adverse effects of overweight and obesity may lead to numerous
severe health impairments which can affect many bodily systems,
including disorders of the cardiovascular (e.g. ischaemic heart dis-
ease), gastrointestinal (e.g. bowel cancer), musculoskeletal (e.g.
osteoarthritis), endocrine (e.g. type 2 diabetes mellitus), and res-
piratory (e.g. obstructive sleep apnoea) systems (Aronne 2002).
In addition to its contribution to specific diseases, obesity can
also negatively impact the psychological well-being of individuals,
and adversely impact societies (through, for example, inhibiting
economic productivity and increasing demands on healthcare re-
sources) (Colditz 1999; Wardle 2005). Overweight and obesity in
childhood and adolescence are associated with increased risks of
overweight and obesity in adulthood (Power 1997). Thus, early
development of overweight and obesity has substantial and long-
lasting consequences for a person’s physical and mental health sta-
tus (Must 1999).
Overweight and obesity are the most often cited effects of a sugar-
rich diet. However, the effects of a sugar-rich diet are far-reaching.
For instance, in theUSA, dental caries is one of themost prominent
childhood diseases with a minimum of one filing or caries lesion
among 77.1% of the children aged 0 to 17 years (Touger-Decker
2003). Worldwide, one in ten people is affected by diabetes (Basu
2013).
Different anthropometric measures, including body weight, BMI,
skinfold thickness, bone-mineral density, waist circumference
(WC), waist-to-hip ratio (WHR), and waist-to-height ratio
(WHtR), are used to evaluate overweight and obesity. Useful mea-
sures are also derived from more advanced measurement tools,
such as bioelectrical impedance analysis (BIA),magnetic resonance
imaging (MRI), isotope dilution analysis (IDA), ultrasound and
computed tomography (CT) (WHO 2000).
Overweight and obesity incur both direct costs (e.g. disease-re-
lated preventive, treatment and diagnosis service costs) and indi-
rect costs (e.g. disease-related costs of lost productivity) (Van Nuys
2014; Wolf 1998). A systematic review on the direct costs of obe-
sity estimated that it accounts on average for 0.7% to 2.8% of
a country’s total healthcare expenditure (Withrow 2011). In the
USA, 5% (equal to 120.1 billion US dollars) to 10% of the total
healthcare costs arise as a consequence of overweight and obesity
(Tsai 2011). Indirect costs of overweight and obesity are higher
than direct costs, accounting for 54% to 59% of the total cost esti-
mates (Dee 2014). Moreover, a systematic review reports on over-
weight and obesity affecting wage penalties specifically in white
females in the USA.Weight differences of two standard deviations
(about 65 pounds) were found to result in a wage difference of 9%
(Cawley 2004).
Description of the intervention
Food-related fiscal policies
Food-related fiscal policiesmay either aim to lower prices (e.g. sub-
sidisation) or increase prices for specific goods (e.g. taxation). We
will evaluate the effects of imposed taxes on unprocessed sugar and
sugar-added foods. The Organization for Economic Co-Opera-
tion and Development (OECD) defines taxes as “compulsory un-
requited payments to general government” (OECD 2014). There
are two types of taxes on products: (1) indirect taxes levied within
national borders (e.g. sales tax, value added tax (VAT), excise tax),
and (2) import taxes including custom duties and import sales
taxes (Fletcher 2010; Meessen 2007; Mytton 2012).
Indirect taxes are paid by the consumer, collected by the seller or
intermediary, and forwarded to government. Sales taxes - as one
form of indirect taxes - are paid by the consumer at the moment of
purchase of the taxed goods and services. Sales taxes are frequently-
implemented tax interventions to reduce the consumption of a
specific good, such as unprocessed sugar or sugar-added foods
(Brownell 2009). The VAT is themost popular tax across the globe
and the major form of indirect tax. The term “VAT” is used as a
synonym for “goods and service tax”. The underlying principle of
the VAT system includes “the application to goods and services of a
general tax on consumption exactly proportional to the price of the
goods and services” (Schenk 2015). The VAT is more commonly
applied to different food categories as compared to targeted food
taxes (Mytton 2007). The level of a sales tax may differ according
to the type of product and service. Sales taxes and VAT are added
to the price of an item and they do not consider the volume of
the item. Thus, goods of a larger size are comparably cheaper
than the same goods of smaller sizes, resulting in a lower impact
of the tax in goods with larger package sizes. An excise tax is an
inland tax on the (production for) sale and the goods produced for
sale. In contrast to indirect taxes, custom duties are taxes applied
to imported products. The Cook Islands and Fiji implemented
custom duties (also called “border taxes”) on SSBs to increase the
cost of these drinks and to fight the obesity epidemic (Snowdon
2013). Import sales taxes are applied similarly. An import sales
tax is a tax on goods imported from countries which are not a
contracting party of the importing country (Cnossen 1993). All
taxes may encourage reformulation of the taxed item.
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Fiscal policies such as excise taxes on food have been proposed,
developed and implemented, generally with the goal of curbing
overweight and obesity, but sometimes also for the purpose of in-
creasing governmental revenue (Kim 2006). Taxes raise revenue
for government and these revenues may or may not be hypoth-
ecated for public health programs. These types of food taxation
policies include taxes on salt, fats, SSBs, and unprocessed sugar
or sugar-added foods (other than beverages) more generally. This
review will focus specifically on the taxation of unprocessed sugar
and sugar-added foods.
The underlying policy and economic rationale for implementing
food taxation policies, including those on unprocessed sugar and
sugar-added foods, is a government’s motivation to create or in-
crease a financial charge for a specific good in order to increase
consumer prices and usually also to raise revenues. This may lead
to a decrease in demand with the intention to reduce the intake
of this food product by changing consumption patterns (Ecorys
2014). As a response to the implementation of a tax on unpro-
cessed sugar or sugar-added foods, food industries may reformu-
late their products (Brownell 2009). This may lead to products
with lower added sugar content. However, this reformulation of
the product may make it even unhealthier, e.g. by adding other
ingredients, such as fat.
This review will examine studies with artificial increases of selling
prices for unprocessed sugar and/or food products that contain
added sugar (e.g. sweets, ice cream, confectionery, bakery prod-
ucts) regardless of the taxation level.
In this review, the taxation - as a form of intervention - focuses on
unprocessed sugar and sugar-added foods.
How the intervention might work
See Figure 1.
Figure 1. Study’s Logic Model with Causal Pathways
The typical aim of effective prevention and treatment of over-
weight and obesity is weight reduction. This can be achieved by
decreasing energy intake through changes in dietary habits (e.g.
reducing consumption of foods high in added sugar and fats), drug
treatment, a surgical intervention, and/or increased energy expen-
diture through physical activity (Wadden 2002). Taxation of food
might be an effective mechanism in the reduction of overweight
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and obesity prevalence.
In general, food taxes are oftenhypothesised to lead to better health
outcomes (Mytton 2012). However, the decrease in the percentage
share of unprocessed sugar and sugar-added foods consumption
in the total energy intake is likely to have one of two effects on
health-related behavior: it may either lead to a reduction in total
daily energy intake, or the consumption of unprocessed sugar and
sugar-added foods may be substituted by other products that are
unhealthy, such as cigarettes and salt for example, or foods that
are also relatively high in calories (e.g. high fat content) (Briggs
2013). While the former may lead to weight reduction, the latter
may result in (1) weight gain, (2) a zero effect, or (3) weight
reduction (Ecorys 2014). However, the effects of food taxation on
public health and consumption patterns take some time to become
detectable (Fletcher 2010; Meessen 2007).
According to economic theory, the taxation of unprocessed sugar
or sugar-added foods is expected to cause an increase in price
which in turn will lead to a decrease in demand, sales, and con-
sumption (Mytton 2012). Moreover, with regard to within-coun-
try inequalities, as the price of a product determines the level
of affordability, low-income groups are usually more strongly af-
fected by taxation policies than higher-income groups (Eyles 2012;
Maniadakis 2013). If low-income populations have higher preva-
lences of overweight, obesity, type 2 diabetes, dental caries and
other sugar-related diseases and conditions thanmiddle- and high-
income populations, then unprocessed sugar or sugar-added foods
tax policies may disproportionately reduce consumption of un-
processed sugar and sugar-added foods among the low-income
population, and thus improve health equity in the population.
Furthermore, with regard to between-country inequalities, these
tax interventions may reduce overweight, obesity, type 2 diabetes,
dental caries and other sugar-related diseases and conditions dif-
ferently across countries of different income levels. For example,
it is theoretically plausible that such taxes are more effective in re-
ducing sugar-related diseases and conditions in low-income coun-
tries than in middle- and high-income countries. Thus, taxes on
unprocessed sugar and sugar-added foods have the potential to
also improve between-country health equity (Eyles 2012; Lorenc
2012; Maniadakis 2013).
In some countries, taxes on unprocessed sugar and sugar-added
foods have already been implemented. For example, Norway
taxes unprocessed sugar and chocolate (Ecorys 2014; Norwegian
Ministry of Finance 2014); Finland taxes ice cream and confec-
tionery (Ecorys 2014); Hungary taxes pre-packaged foods high
in added-sugar content (i.e. chocolates, sweets, biscuits and ice
creams) (Ecorys 2014;Holt 2011), andDenmark temporary taxed
ice cream, chocolate and confectionery (Wilkins 2010).
Our concept of the taxation of unprocessed sugar and sugar-added
foods is described in a logic model with causal pathways in Figure
1. The taxation of unprocessed sugar and sugar-added foods - in-
troduced by local, regional, national, and multinational govern-
ments - is hypothesised to result in price changes (e.g. increased
prices of chocolate, ice cream, andbakery products) (Epstein 2012;
Jensen 2013;Maniadakis 2013), which in turn may lead to altered
expenditure patterns for food. Financial resources - also dependent
on expenditures on food - and contextual and individual factors
(e.g. income), determine the demand for food products. These
market components impact consumer purchases and consump-
tion choices for different food categories, including unprocessed
sugar and sugar-added foods (Briggs 2013; Sharma 2014). This
may result in a lower intake of the taxed food products (unpro-
cessed sugar and sugar-added foods) and in a substitution of these
by other (food) products (Fowler 2015; Yang 2010). As a conse-
quence, food tax-induced changes in consumption patterns result
directly in changes to unprocessed sugar and sugar-added foods
intake (Epstein 2012; Maniadakis 2013). A decrease in the intake
of unprocessed sugar and sugar-added foods - as one hypothesised
consequence of taxing these foods - can reduce overweight, obesity,
and other health outcomes directly and indirectly. To exemplify
the direct path from the intake of unprocessed sugar and sugar-
added foods to other health outcomes, a decrease in the intake
of unprocessed sugar and sugar-added foods has the potential to
reduce the risk of dental caries (Moynihan 2014; WHO 2015a).
The indirect path from the intake of unprocessed sugar and sugar-
added foods to overweight and obesity goes through energy in-
take. For example, a decreased energy intake as a consequence of
decreased intake of unprocessed sugar and sugar-added foods can
result in lower risks for overweight and obesity (Kim 2006; Malik
2013). Moreover, food tax-induced changes in consumption pat-
terns may directly result in changes in nutrient intake (Epstein
2012; Maniadakis 2013). The direct path from intake of other
nutrients (e.g. fat or dietary minerals) as a consequence of sub-
stitution effects has the potential to directly increase, decrease or
not affect the risk of other health outcomes (e.g. fatty liver). The
indirect path from intake of other nutrients to overweight, obesity
and other health outcomes goes through energy intake. To illus-
trate this, a higher intake of other nutrients (e.g. saturated or un-
saturated fat) as a substitution effect of decreased intake of unpro-
cessed sugar and sugar-added foods affects energy intake (increase,
decrease or zero effect) and is therefore associated with the risk of
overweight, obesity and other health outcomes (Marriott 2010).
Decreased risks of overweight and obesity, in turn, can reduce the
risk of developing other diet-related diseases and conditions (e.g.
chronic diseases such as type 2 diabetes, cardiovascular diseases,
dental caries) (Guh 2009).
Contextual and individual factors influence the process from the
input to the outcomes, alter effect sizes and help us to understand
the causal relationships (Qi 2012). Alternative interventions may
be possible comparators but also potential co-interventions (i.e.
complementary interventions to reduce the consumption of un-
processed sugar and sugar-added foods, such as bans onmarketing,
which are designed to enhance intervention effectiveness). There-
fore the effect of taxation may be modified by other interventions
by governments, communities and the food industry to reduce
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consumption of unprocessed sugar and sugar-added foods (Jou
2012; Thow 2011). Social factors such as gender and educational
qualification may determine the effectiveness of a tax intervention,
and tax interventions may thus impact health equity (Anderson
2011b).
Why it is important to do this review
There is increasing public health interest in the taxation of un-
processed sugar and sugar-added foods as an intervention, follow-
ing recently implemented food taxes in countries such as Mexico.
However, the implementation of a tax on unprocessed sugar and
sugar-added foods is only one of many policy options for reducing
consumption of these foods (Hawkes 2015).
Consumption of unprocessed sugar and sugar-added foods is far
above recommended levels. Data from 2010 and 2011 suggest
that the average daily per capita consumption of sugar is about
63 grams. This differs by country, with the lowest intake being
observed in Bangladesh (approx. 22 grams) and the highest in
Israel (approx. 181 grams) (Groupe Sucre et Denrées 2015).
WHO recommends a daily sugar consumption of less than 10% of
the total energy intake. Thus, the recommended maximum level
in adults is approximately 50 grams. Keeping the daily sugar in-
take on a level below 5% (approx. 25 grams) of the recommended
total energy intake might have even greater health benefits (WHO
2015a). In view of the excess consumption of sugar and the world-
wide increase in overweight and obesity prevalence, governmen-
tal action is urgently required. Taxes for unprocessed sugar and
sugar-added foods are interventions that may fulfil the policy aim
of reducing the prevalence and healthcare costs of overweight and
obesity.
Previous systematic reviews have investigated relevant public
health effects of taxing fast food (Powell 2013), SSBs (Maniadakis
2013; Powell 2013; Welsh 2013), and saturated fat (Eyles 2012;
Maniadakis 2013; Powell 2013), and subsidies of fruits and vegeta-
bles (Eyles 2012; Powell 2013), or all foods (Green2013;Niebylski
2015; Powell 2013). Some of these reviews have combined diverse
fiscal policy interventions in assessing the association between food
pricing strategies and relevant public health outcomes (Maniadakis
2013; Powell 2013; Welsh 2013). Results as to the effectiveness
of fat taxes and food subsidies are inconsistent across systematic
reviews, suggesting no effects (Maniadakis 2013; Powell 2009) or
beneficial effects for relevant public health outcomes (Eyles 2012;
Green 2013; Powell 2013). Inconsistency of results across system-
atic reviews may arise from the investigation of different policy
interventions, the inclusion of studies differing across the popula-
tions’ SES, and inclusion of different study types (e.g. modelling
studies only or cross-sectional studies in combination with other
study types).
This review is different to previous reviews that investigated the ef-
fectiveness of food taxes and subsidies for the improvement of pop-
ulation health and changes in consumption patterns (Eyles 2012;
Maniadakis 2013; Niebylski 2015; Powell 2009; Powell 2013).
This is the first systematic review to investigate the effects of taxes
of unprocessed sugar and non-liquid sugar-added foods. Evidence
is required regarding the effectiveness of taxing unprocessed sugar
and sugar-added foods so that policy makers can make evidence-
based decisions.
This research will be part of a set of three systematic reviews of
different types of food taxation carried out by the same author
group using a similar methodological approach. For reasons of
comparability, the methodological content is similar across the
three reviews. These reviews will focus on the effects of govern-
mental taxation to increase the prices of: (1) unprocessed sugar or
sugar-added foods (this review), (2) processed or packaged food
with high content of saturated fat (Lhachimi 2016), and (3) SSBs
(Heise 2016).
O B J E C T I V E S
To assess the effects of taxation of unprocessed sugar or sugar-
added foods in the general population on the:
1. consumption of unprocessed sugar or sugar-added foods;
2. prevalence and incidence of overweight and obesity; and
3. prevalence and incidence of diet-related health conditions.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Pre-screening of studies evaluating implemented taxation of un-
processed sugar or sugar-added foods revealed heterogeneous study
designs and inherent limitations. Beside small field studies, in-
dividual and cluster randomisation are probably impossible for
evaluations of interventions on unprocessed sugar or sugar-added
foods at the national level (Wansink 2014). Meanwhile, method-
ological limitations inevitably derive from the lack of blinding of
participants and study personnel for the major intervention com-
ponent - changes in prices of products with unprocessed sugar or
sugar-added foods (Block 2010).
Wewill therefore consider evidence from various study designs and
adopt an approach previously used in at least two other Cochrane
reviews in order to summarise ‘best available evidence’ (Gruen
2004; Turley 2013). This approach clearly separates studies into
two broad categories: (1) studies meeting rigorous Cochrane Ef-
fective Practice and Organisation of Care (EPOC) criteria, and (2)
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supporting studies - those not meeting EPOC criteria with greater
risk of bias as well as external generalisability.
First, for the synthesis of main results, in line with EPOC criteria
we will include:
• randomised controlled trials (RCTs);
• cluster randomised controlled trials (cRCTs);
• non-randomised controlled trials (nRCTs);
• controlled before and after (CBA) studies; and
• interrupted time series (ITS) studies.
According to EPOC, controlled studies require more than one in-
tervention or control site and ITS studies require a clearly defined
intervention time and at least three data points before and three
after the intervention (EPOC 2012).
There will be no restriction by publication date and language,
but we will only include studies focusing on human populations
(CPH 2011). We will have no restriction on study duration and
participants. Closed field experiments suggest that consumer be-
haviour adaptations - expressed in terms of unprocessed sugar or
sugar-added foods sales - become apparent within a short time
frame, such as one month (Block 2010). Implementation of taxes
on sugar or sugar-added foods at a national level might feature
a longer time lag between intervention and outcomes, especially
for health outcomes. However, in one study the efficacy of food
taxes with respect to purchases was apparent after one year (Popkin
2016). In general, field experiments on food taxes recruit small
numbers of participants. Nevertheless, they are a valuable source
to identify important outcome pathways and effects on food pat-
terns relevant to the taxation of unprocessed sugar or sugar-added
foods (Epstein 2012).
We will exclude simulation studies, due to their potential limi-
tations provoked by their basic assumptions (e.g. lack of poten-
tial supply-side changes, static models to predict weight loss), and
other methodological restrictions (e.g. the use of a combination
of heterogeneous data sources) (Lin 2011; Shemilt 2015).
Supporting studies
We will include as supporting studies:
• studies that use an RCT, cRCT, nRCT, CBA, or ITS design
but do not fulfil the EPOC criteria (hence, are not included in
the main results as outlined above);
• prospective cohort studies;
• prospective cohort studies;
• retrospective/non-concurrent cohort studies;
• repeated cross-sectional studies; and
• uncontrolled before-after (UBA) studies.
Those studies classified as ’supporting studies’ will not be included
in the statistical synthesis of the primary included studies (i.e. those
meeting EPOC criteria) but will be narratively synthesised in ad-
dition to the main findings. We will extract the same type of data
from these supporting studies as we do for the included studies and
will document these in a separate ’Characteristics of supporting
studies’ table. We will carry out ’Risk of bias’ assessments on these
studies, and undertake quality assessment, utilising the GRADE
approach, and present the findings from these supporting studies
separately, as supplemental information in the results section and
in a separate ’Summary of findings’ table. Observations as to sim-
ilarities and/or differences of findings from the included studies
and the supporting studies will be made in the ’Discussion’ sec-
tion, to help summarise the breadth, quality and the findings of
the totality of research on the effects of these interventions.
Supporting studies may support or challenge results in the main
findings and highlight uncertainty and potential research gaps.We
will consider known limitations of UBA studies, cohort studies,
and repeated cross-sectional studies, especially confounding and/
or time trends, in assessing these studies for inclusion. IfUBA stud-
ies, cohort studies, and repeated cross-sectional studies are likely to
be biased and do not use analytic strategies (e.g. stratification) or
other designs (e.g. regression discontinuity) to control for known
confounders and/or time trends, we will consider excluding these
studies from the ’supporting studies’ analysis.
Types of participants
We will include studies of children (0 to 17 years) and adults (18
years and over) from any country and setting.
We will exclude studies investigating the effects of taxing unpro-
cessed sugar or sugar-added foods focusing on specific subgroups,
particularly:
• people receiving a pharmaceutical intervention;
• people undergoing a surgical intervention;
• pregnant females;
• elite athletes;
• ill people who are overweight or obese as side-effect of their
treatment or condition, such as those with thyroiditis and
depression; and
• people with chronic illness(es);
at baseline and at the post-intervention phase due to higher or
lower health risks compared to the general population.
Types of interventions
This review will include studies of the taxation of unprocessed
sugar or sugar-added foods, defined as:
• a tax of goods;
• imposed by and/or paid to international organisations or
local, regional, or national governments;
• of any value;
• added to sales prices of foods with unprocessed sugar and/
or sugar-added foods, and
• provided for any duration.
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Interventions canbe public policies of local, regional, national, and
multinational governments or they can be field experiments that
imitate taxation effects for research purposes in clearly defined en-
vironments (e.g. cafeterias, supermarkets and vending machines).
We will include any comparator intervention (e.g. no interven-
tion, educational interventions, bans, media campaigns, and sub-
sidies on healthy food). We will also include studies that compare
an eligible tax with another eligible tax that is of a lower value.
Types of outcome measures
Our outcome selection and grouping was guided by preliminary
evidence already discussed in the Background and on the basis of
the logicmodel (Figure 1), and following feedback from the review
advisory board members (email and online survey) (Table 1). All
pre-selected outcomes achieved ’critical’ or ’important’ ratings on
average, following the GRADE approach. For primary outcomes
we favored outcomes of critical importance in line with our review
scope and Objectives (Table 2). Detailed information on advi-
sory group involvement is provided in the section Searching other
resources under the subheading ‘Advisory group’. Primary out-
comes include intermediate non health-related outcomes directly
affected by tax-induced changes in prices for unprocessed sugar or
sugar-added foods. As a result, consumption of unprocessed sugar
or sugar-added foods may directly alter primary health outcomes
including overweight and obesity. Secondary outcomes will focus
on food patterns (substitution and diet), expenditures, and other
health outcomes directly or indirectly influenced by the taxation
of unprocessed sugar or sugar-added foods. We include demand as
a proxy for the consumption of unprocessed sugar or sugar-added
foods.
Primary outcomes
The reviewwill include changes frombaseline to post-intervention
of the following primary outcomes:
Consumption of unprocessed sugar or sugar-added foods
• consumption of unprocessed sugar or sugar-added foods
(e.g. frequency, amount)
Energy intake
• energy intake through unprocessed sugar or sugar-added
foods
• total energy intake
Overweight and obesity
• incidence of overweight and obesity
• prevalence of overweight and obesity
All outcomes can be measured by physicians and other profes-
sionals, or self-reported. Overweight and obesity can be measured
by different anthropometric body mass indices (e.g. BMI, WC,
WHR, WHtR, etc.). We will report changes in body mass indices
if no data are available on incidence or prevalence of overweight
and obesity.
Secondary outcomes
The reviewwill include changes frombaseline to post-intervention
of the following secondary outcomes:
Substitution and diet
• composition of diet (expressed as food groups or
ingredients e.g. fat, sugar, salt, alternative low-caloric sweeteners)
Expenditures
• total expenditures on food
• total expenditures on unprocessed sugar or sugar-added
foods
Demand
• total sales of unprocessed sugar or sugar-added foods
Other health outcomes
• health-related quality of life (e.g. Short Form 36 (SF-36),
Health-Related Quality of Life (HRQOL-14))
• mortality
• any other health outcomes (e.g. dental caries, type 2
diabetes, cardiovascular diseases, etc.)
Outcomes can be measured by physicians and other professionals,
or self-reported.
Search methods for identification of studies
Electronic searches
We will search the following 12 databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL) (1948 to present);
• Cochrane Database of Systematic Reviews (CDSR) (1995
to present);
• MEDLINE via OvidSP (1946 to present);
• Excerpta Medica database (Embase) via OvidSP (1947 to
present);
• PsycINFO via OvidSP (1887 to present);
• Current Contents Medicine Database of German and
German-Language Journals (CCMed) via LIVIVO (2000 to
present);
• Latin American and Caribbean Health Sciences (LILACS)
via BIREME/VHL (1982 to present);
• EconLit via EBSCO (1969 to present);
• Campbell Library via Campbell Collaboration (2004 to
present);
• Food Science and Technology Abstracts (FSTA) via OvidSP
(1969 to present);
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• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) via EBSCO (1937 to present);
• Web of Science (SCI-EXPANDED, SSCI, A&HCI, CPCI-
S, CPCI-SSH, ESCI, CCR-EXPANDED, IC) via Thomson
Reuters (1900 to present).
We will apply a search strategy with additional keywords for pos-
sible comparators (e.g. “subsidy”) and we will not use filters for
study types, in order to maximise the sensitivity of the literature
search (Higgins 2014, chapter 6.4.4). We present the strategy to
search MEDLINE in Appendix 1. We will modify this strategy to
fit the syntax of other databases. We will not search African Index
Medicus (AIM) - a valuable resource for low- and middle-income
country literature - in our review, as a sensitive pre-search with
intervention keywords (e.g. tax, taxation etc.) resulted in zero hits.
Grey literature databases
We will search the following six grey literature databases:
• ProQuest Dissertations & Theses Database (PQDT) via
ProQuest;
• System for Information on Grey Literature in Europe -
OpenGrey via INIST/CNRS;
• The Directory of Open Access Repositories - OpenDOAR
via CRC;
• EconPapers via ORU;
• Social Science Research Network - SSRN eLibrary via
SSRN;
• National Bureau of Economic Research (NBER) via NBER.
We will search the following two databases for completed or on-
going studies:
• WHO International Clinical Trials Registry Platform
(WHO ICTRP) (includes references of the ClinicalTrials.gov
database); and
• Trials Register of Promoting Health Interventions
(TRoPHI);
with keywords relevant to the intervention (e.g. taxation, pricing).
Internet search engines
The first 30 hits inGoogle Scholar will be screened.Wewill use the
same terms as in our searches of the academic and grey literature
databases.
Targeted internet searching of key organisational and
institutional websites
We will search websites of major organisations and institutions,
specifically:
• World Obesity Federation (www.worldobesity.org);
• The Obesity Society (www.obesity.org);
• OECD (www.oecd.org);
• WHO (www.who.int);
• European Commission (ec.europa.eu/index˙en.htm);
• DG Sanco (ec.europa.eu/dgs/health˙food-safety/
index˙en.htm);
• Centers for Disease Control and Prevention (www.cdc.gov);
• National Institute for Health and Care Excellence (
www.nice.org.uk);
• World Trade Organization (www.wto.org);
• World Cancer Research Fund Institute (www.wto.org).
Searching other resources
We will handsearch the reference list of all records of included
studies.
Advisory group
We have established a review advisory group of experts in the field
of food taxation and health to comment and to provide advice
and suggestions to improve the manuscript in the protocol and re-
view stages. Following the GRADE approach, the advisory group
members participated in an online survey and ranked pre-selected
outcomes according to their relative importance on a 9-point Lik-
ert scale (categories: 1 to 3: of limited importance; 4 to 6: impor-
tant; 7 to 9: critical) (GRADE 2013). The review advisory group
consists of policymakers, researchers and academics.
We have provided the members of the review advisory group with
detailed background information on this review. At the protocol
stage, the review advisory group members were asked to provide
feedback specifically on the focus and the relevance of this review’s
research question, selected endpoints, study design, search strategy,
database selection, and ongoing or unpublished studies (Higgins
2014, chapter 2.3.4.3). We received feedback via email and the
online survey. All members of the advisory group and results from
the online survey are found in Table 1 and Table 2 .
Data collection and analysis
Selection of studies
An information specialist will conduct the database searches. We
will conduct screening in six stages. If a reference, an abstract or
a full-text report is in a language other than English, German or
French, translation will be performed by internet-based transla-
tion tools or by native speakers. First, studies’ titles and abstracts
(when available) will be reviewed by at least two authors inde-
pendently. If an abstract is not provided by the database it orig-
inates from, and the title appears to be potentially relevant, we
will progress the record to full-text review. Second, both review
authors will compare their list of relevant studies and in the case of
any disagreement the opinion of a third author will be sought to
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achieve consensus. Third, full texts of potentially relevant studies
will be retrieved or obtained. Fourth, the full texts will be screened
by the two authors independently. Fifth, both authors will create
a list with studies that are considered to fulfil the inclusion crite-
ria. Sixth, the authors will compare their list with each other and
in case of any disagreement the opinion of a third author will be
decisive. Based on these six steps, studies will be included in the
review. We will present a PRISMA flowchart to display the selec-
tion of included studies (Liberati 2009).
Data extraction and management
Data extraction will be performed independently by at least two
authors, who will both compare the extracted data. Disagreements
will be resolved by a third author. We will use a modified data
extraction and assessment template from Cochrane Public Health
(CPH) (CPH 2011). Prior to themain data extraction process, the
authors will pilot the data extraction form to ensure standardised
extraction (Higgins 2014, chapter 7.6.3). We will extract general
information (publication type, country of study, funding source
of study, potential conflict of interest), study eligibility (type of
study, participants, type of intervention, duration of intervention,
and type of outcome measures), study details (study aim, meth-
ods, results, intervention group, confounders, and confounder-
adjusted and unadjusted outcomes), indicators of changes in food
prices (price of unprocessed sugar or sugar-added foods, price of
other food categories), and other relevant information. Effect es-
timates for study populations based on PROGRESS categories
(place of residence, race/ethnicity/culture/language, occupation,
gender/sex, religion, education, socioeconomic status, social cap-
ital) will be extracted to evaluate impacts on equity. We will also
extract contextual factors (e.g. political system, co-interventions,
reason for implementation, reason for particular tax level, intended
beneficiaries, implementation costs, country and region-specific
level of gross domestic product (GDP), food security (availability,
access, and use)), and process evaluation criteria (e.g. satisfaction
of participants, adherence) that facilitate or hinder the implemen-
tation of the taxation on unprocessed sugar or sugar-added foods
(Anderson 2011a).
Data will be entered into RevMan 5.3 by one author, and a second
author will double-check the data entered (RevMan 2014).
Assessment of risk of bias in included studies
The risk of bias of every included study will be evaluated inde-
pendently by at least two authors. In case of any disagreement,
discrepancies will be discussed with a third author and resolved
by consensus. Based on the template provided by CPH, the risk
of bias will be assessed using the criteria for judging risk of bias in
Cochrane’s ‘Risk of bias’ assessment tool (Higgins 2011) and the
Cochrane Effective Practice and Organisation of Care (EPOC)
Group’s guidance (EPOC 2015). Both tools examine the follow-
ing biases: selection, performance, detection, attrition, reporting,
and others. The EPOC ’Risk of bias’ tool for ITS examines three
further risks of bias: “Was the intervention independent of other
changes?”, “Was the shape of the intervention effect pre-specified?”
and “Was the intervention unlikely to affect data collection?”. For
studies included in the main synthesis (i.e. RCTs, cRCTs, nRCTs,
CBA and ITS studies), we will assess the risk of bias using the
’Risk of bias’ criteria for EPOC reviews, based on the Cochrane
Collaboration’s tool for assessing risk of bias (Higgins 2014, Table
8.5.a).
Study quality and risk of bias of ’supporting studies’ (i.e. studies
that do not meet EPOC criteria, cohort studies, repeated cross-
sectional studies, uncontrolled before and after studies) will be as-
sessed with the Quality Assessment Tool for Quantitative Studies,
developedby theEffective PublicHealth Practice Project (EPHPP)
(EPHPP 2007).
To judge the risk of bias according to Cochrane’s ‘Risk of bias’
assessment tool, the following three categories will be used: “low”,
“high”, and “unclear” (adequate information is unavailable or there
is uncertainty about the risk of bias) (Higgins 2014, chapter 8.6).
To judge the risk of bias according to the Quality Assessment Tool
for Quantitative Studies, the following three categories will be
used: “strong”, “moderate”, and “weak” (EPHPP 2007). We will
provide ’Risk of bias’ tables for all included studies.
Measures of treatment effect
Data synthesis aims to pool the results of different studies. Effects
of the treatment on dichotomous outcomes will be reported as
odds ratios (ORs), risk ratios (RRs) or risk differences (RDs). In
accordance with the recommendations fromCPH, RRs will be the
preferred reporting measure of treatment effect (CPH 2011). If
RRs are not presented in the study, but data to calculate the RRs are
provided, we will calculate them. This also applies to data suitable
to calculate ORs (e.g. obesity prevalence). If data to calculate the
RRs are not provided, we will contact the corresponding author
of the study, by email or phone, to request the RRs or the data
to calculate the RRs. If we cannot obtain RRs, we will report the
treatment effect from the study report.
Continuous data will be expressed as mean differences (MDs)
where applicable, or as standardised mean differences (SMDs).
Shorter ordinal data will be translated into dichotomous data (ex-
pressed asORs,RRs orRDs) and longer ordinal datawill be treated
as continuous data (expressed as MDs or SMDs). It is unclear
whether there is a cut-off point which is common across the stud-
ies and can be used for dichotomisation (Higgins 2014, chapter
7). The cut-off point will be part of the sensitivity analysis. Count
data and Poisson data will be expressed as rate ratios. Time-to-
event data (survival data) will be translated into dichotomous data
when appropriate, or into hazard ratios (HRs).
If feasible, we will report the adjusted treatment effect. If a study
does not present adjusted treatment effect measures, we aim to
adjust the treatment effect measures for baseline variables by addi-
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tional multivariate analyses as far as we have access to the dataset,
or by contacting the corresponding author of the study by email
or phone for the adjusted treatment effect measures. If studies
present intention-to-treat effect estimates, then we will prioritise
these over average causal treatment effect estimates (Higgins 2014,
chapter 9).
Conversion of cost estimates will be used to harmonise food expen-
diture outcomes and contextual data (e.g. implementation costs).
Cost data of included outcomes will be pooled for meta-analysis if
possible. When the treatment effect is described in cost estimates
as derived from economic studies, we will convert the cost esti-
mates to US dollars (USD) and the price year 2015 to compare
cost estimates from different studies with each other. To convert
cost estimates into USD, we will apply an international exchange
rate based on Purchasing Power Parities (PPPs). To convert cost
estimates to the year 2015, we will applyGDP deflators or implicit
price deflators for GDP. PPP conversion rates and GDP deflator
values will be derived from the International Monetary Fund in
the World Economic Outlook Database (www.imf.org/external/
data.htm) (Higgins 2014, chapter 15.6.1).
Unit of analysis issues
We will collect data on studies irrespective of whether individuals
or groups are allocated to an intervention or control group. The
analysis will consider the level at which allocation occurred, e.g.
cluster-randomised trials, cross-over trials, and multiple observa-
tions (repeated observations on subjects, recurring events, multi-
ple body parts, and multiple intervention groups) for the same
outcome (Higgins 2014, chapter 9.3.1). As far as possible, we
will consider data from cross-over trials (e.g. by incorporating the
study data similar to a parallel group trial) and studies with mul-
tiple observations (e.g. by defining different periods of follow-up)
(Higgins 2011, chapter 9.3.4; chapter 16.4.5).
If control for clustering is missing or, insufficient and if individual-
level data are not presented in the study, wewill request individual-
level data from the corresponding author of the study. If feasible,
we will reduce the size of each trial to its ‘effective sample size’ in
order to correct intervention effects of cluster-randomised trials.
The effective sample size of an intervention group is the original
sample size divided by the ‘design effect’. We will calculate the
design effect by the formula 1 + (M - 1) ICC. M is the average
cluster size and ICC is the intracluster correlation coefficient (
Higgins 2014, chapter 16.3.4).
For dichotomous data, the total number of participants and the
number of participants who experience the event will be divided
by the same design effect. For continuous data, only the sample
size will be reduced; means and standard deviations will remain
unchanged (Higgins 2014, chapter 16.3.4).
Dealing with missing data
We will request all missing information and data from principal
study authors via email or phone. The following steps will be taken
to deal with relevant missing data:
• contact the authors;
• screen the study and investigate important numerical data
such as randomised individuals as well as intention-to-treat
(ITT), as-treated and per-protocol (PP) populations;
• investigate attrition rates as part of the ’Risk of bias’
assessment in terms of drop-outs, losses to follow-up and
withdrawals;
• critically appraise issues of missing data and imputation
methods (e.g. last observation carried forward (LOCF));
• impute missing standard deviations if contacted authors do
not respond (Higgins 2014, chapter 16.1);
• apply sensitivity analyses to estimate the impact of
imputation on meta-analyses.
Data “not missing at random” due to systematic loss to follow-
up or systematic exclusion of individuals from studies will be
requested from principal study authors (Higgins 2014, chapter
16.1.2).
Assessment of heterogeneity
In the event of substantial conceptual, methodological or statistical
heterogeneity, we will not perform meta-analytic pooling.
Heterogeneity will be detected through visual inspection of the
forest plots and by using a standard Chi² test with a significance
level of P < 0.1 (Higgins 2014, chapter 9.5.2). The I² statistic will
be applied and considered to quantify inconsistency across studies
and to assess the impact of heterogeneity on the meta-analysis
(Higgins 2014, chapter 9.5.2).
Methodological heterogeneity and PICO (population, interven-
tion, comparison, outcome) heterogeneity will be assessed with ta-
bles and explanations inside the review. We will consider potential
sources of heterogeneity, such as:
• study population;
• intervention area/setting;
• intervention characteristics (tax definition, basis for
calculating taxation, level of taxation);
• implementation level;
• comparisons;
• co-interventions; and
• outcomes.
Assessment of reporting biases
Reporting bias, including publication bias, time lag bias, multi-
ple (duplicate) publication bias, location bias, citation bias, lan-
guage bias, and outcome reporting bias occur when the dissemi-
nation of research results depends on their magnitude and/or di-
rection (Higgins 2014, chapter 10). If we find 10 or more stud-
ies of the same outcome, we will produce funnel plots and assess
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these plots for study effects resulting from reporting biases. When
testing asymmetry in funnel plots (small study effects), we will
investigate whether the relationship between a measure of study
size and the estimated intervention effect is asymmetrical (Higgins
2014, chapter 10). We will draw funnel plots using RevMan 5.3
(RevMan 2014).
Data synthesis
If two ormore studies report the same outcome and are sufficiently
homogenous conceptually, methodologically, and statistically, we
will perform meta-analyses of these studies, using RevMan 5.3
(RevMan 2014). For dichotomous outcomes, we will apply the
Mantel-Haenszel method, and for continuous outcomes, we will
apply the inverse variance method. For all analyses, the random-
effects method will be used as we expect differences in the un-
derlying effect sizes due to contextual and implementation differ-
ences (Higgins 2014, chapter 9.5.4). If a study reports two ormore
measures for the same outcome, then we will report the measure
that is most commonly reported by the other included studies.
If a study reports multiple follow-ups for the same outcome (e.g.
six months during the intervention, one year during the interven-
tion, and six months after the intervention), we will prioritise the
longest follow-up during the intervention (e.g. one year during
the intervention, in the example given). Nevertheless, all follow-
up data will be extracted.
Study results with insufficient homogeneity will be narratively
synthesised. We will structure narrative synthesis by the outcome
categories of this review. Within these categories, we will make
further separation according to the intervention setting and the
study design or study quality (Ryan 2016). In addition to report-
ing findings as text and tables, we may consider both harvest plots
and effect direction plots to summarise data not suitable for meta-
analyses.Harvest plots are graphical summaries of data represented
by multiple shaded or non-shaded bars with varying heights, and
can be utilised to indicate effect directions across included studies
with non-standardised effect estimates of outcomes (e.g. anthro-
pometric measures). Similarly, effect direction plots can be used
to visualise information on effect directions, with more focus on
direct comparisons across studies (Ogilvie 2008; Thomson 2013).
We will provide a ‘Summary of findings’ table with primary and
secondary outcomes (Higgins 2014, chapter 11.5). This will in-
clude incidence/prevalence of overweight/obesity, consumption of
unprocessed sugar and sugar-added foods, energy intake (total/
via unprocessed sugar and sugar-added foods), substitution with
other foods/nutrients, sales/expenditures on unprocessed sugar
and sugar-added foods/foods in general, diabetes and other health
outcomes. This pre-selection of outcomes is based on external ref-
eree suggestion.
These tables will include information on the outcomes, illustra-
tive comparative risks, the relative effect, the number of partic-
ipants, the number of studies included, the quality of evidence
based on the GRADE guideline, and additional comments. If fea-
sible, we will use the computer software GRADEprofiler Guide-
line Development Tool to prepare the ‘Summary of findings’ table
(GRADEpro GDT). Furthermore, results of data synthesis will
be mapped against our initial logic model, to refine the theory of
change and assess the credibility of the assumed causal pathways
(Anderson 2011a; Thomson 2013).
Subgroup analysis and investigation of heterogeneity
Wewill conduct meta-analyses and harvest plots for studies assess-
ing the following subgroups for primary outcomes, where feasible:
• high-income countries versus middle- and low-income
countries;
• high-income groups versus middle- and low-income groups;
• high-educated groups versus low-educated groups;
• different tax values of unprocessed sugar or sugar-added
foods;
• single tax on unprocessed sugar or sugar-added foods versus
multiple taxes on unprocessed sugar or sugar-added foods;
• tax on unprocessed sugar or sugar-added foods alone versus
tax on unprocessed sugar or sugar-added foods accompanied by
other fat taxes or interventions (e.g. bans, minimum pricing,
media campaigns, or subsidies on healthy foods);
• different types of taxation: (1) indirect taxes levied within
national borders (e.g. excise tax, sales tax, value added tax
(VAT)); and (2) import taxes including custom duties and
import sales taxes;
• children versus adults;
• BMI subgroups;
• indigenous populations;
• chronically ill people with overweight and obesity as side-
effects.
If data are available in PROGRESS categories (e.g. age, gender, ed-
ucation, and ethnicity), we will perform additional subgroup anal-
yses according to these social determinants of health (Anderson
2011b).
If feasible, we will investigate the statistical significance of differ-
ences in the treatment effect between subgroups using t-tests and
Chi² tests (Higgins 2011a, chapter 9.6.2).
Sensitivity analysis
Sensitivity analyses will be performed to determine the robustness
of our results by conducting meta-analyses and harvest plots for
the studies included in our review:
• with respect to source of funding;
• with studies considered as ‘low risk of bias’ compared to
studies considered as ‘high risk of bias’;
• with published versus unpublished studies;
• with respect to the intervention duration;
• with respect to follow-up time;
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• with objective measures versus subjective measures;
• with respect to study design;
• with respect to cut-off points of the measures of treatment
effect;
• with respect to imputation of data.
Studies assessed as having a high or unclear risk of bias with respect
to incomplete outcome data and baseline differences will not be
included in these analyses. For cRCTswith adequate data provided,
we will perform intracluster correlation value sensitivity analysis.
We will report findings of sensitivity analyses as a summary table
(Higgins 2011a, chapter 9.7).
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A D D I T I O N A L T A B L E S
Table 1. Advisory group members
Name Occupation
Cristina Cleghorn Department of Public Health, University of Otago, Wellington, NZ
Emilia Crighton Faculty of Public Health, London, UK
Peter Faassen de Heer CMO and Public Health Directorate Scottish Government, Edinburgh, UK
Dionne Mackison Department for International Development, UK Government, Glasgow, UK
Barry Popkin Professor of Global Nutrition, University of North Carolina, Chapel Hill, US
Torben Jørgensen Professor Department of Public Health University of Copenhagen, Copenhagen, DK
Table 2. Feedback advisory group (online survey)
1.1. Rank outcomes according to their relative importance for the scope of the reviews and general public health decision-
making in the context of food taxation; 9-point Likert scale (categories: 1 to 3 - of limited importance; 4 to 6 - important; 7
to 9 - critical)
Outcomes: Average score: Rank:
prevalence of overweight 7.67 3
prevalence of obesity 7.67 3
incidence of overweight 8.00 1
incidence of obesity 8.00 1
caloric intake through SSBs or unprocessed
sugar/sugar-added foods
7.33 8
total calorie consumption 6.67 11
consumption of SSBs or unprocessed
sugar/sugar-added foods (e.g. frequency,
amount)
7.33 8
health-related quality of life 4.00 16
total sales of SSBs or unprocessed sugar/
sugar-added foods
5.33 15
composition of diet (e.g. fat, sugar, salt) 6.67 11
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Table 2. Feedback advisory group (online survey) (Continued)
total expenditures on food 4.00 16
total expenditures on SSBs or unprocessed
sugar/sugar-added foods (e.g. frequency,
amount)
5.67 14
any health outcomes or health-related un-
intended consequences
7.67 3
e.g. mortality 7.00 10
e.g. dental caries 6.00 13
e.g. diabetes 7.67 3
e.g. CVD 7.67 3
2.1. How well do the presented outcomes cover the basic review scope?
Answers: Rating: Number of responses:
Important outcomes are presented 66.67% 2
Important outcomes are missing 33.33% 1
Comments (1): I imagine some evidence will be presented as simply a change in BMI or other markers
of obesity rather than a change in incidence or prevalence of obesity (Cristina Cleghorn)
3.1. Do you think the same outcomes are appropriate for both reviews (SSB; sugar or sugar added foods)?
Answers: Rating: Number of responses:
The same group of outcomes should be
utilised in both reviews
66.67% 2
Different outcomes should be utilised in
the two reviews
33.33% 1
Comments (1): Foods study:Hard to go beyond kcal and weight andminimal cardiometabolic outcomes
as the Morenga et al. review shows (Barry Popkin)
Participants n = 3
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp Taxes/
2. exp Government Programs/ec, lj [Economics, Legislation & Jurisprudence]
3. exp Health Policy/ec, lj [Economics, Legislation & Jurisprudence]
4. exp Food Dispensers, Automatic/ec, lj, sn [Economics, Legislation & Jurisprudence, Statistics & Numerical Data]
5. exp Health Promotion/ec, lj [Economics, Legislation & Jurisprudence]
6. exp Nutrition Policy/ec, lj [Economics, Legislation & Jurisprudence]
7. exp Public Health/ec, lj [Economics, Legislation & Jurisprudence]
8. “demand elasticity”.tw.
9. “policy intervention*”.tw.
10. “sales tax”.tw.
11. “thin subsidies”.tw.
12. “vending machine*”.tw.
13. budget.tw.
14. excise.tw.
15. fiscal.tw.
16. levied.tw.
17. levy.tw.
18. price.tw.
19. priced.tw.
20. prices.tw.
21. pricing.tw.
22. subsidy.tw.
23. subsidies.tw.
24. tax.tw.
25. taxation.tw.
26. taxed.tw.
27. taxes.tw.
28. taxing.tw.
29. OR/1-28
30. exp Dietary Carbohydrates/
31. exp Dietary Sucrose/
32. exp High Fructose Corn Syrup/
33. “chewing gum”.tw.
34. “dietary sucrose”.tw.
35. ((“energy dens*” or “highenergy” or “high energy” or “high-energy” or “low energy” or chips) and (fat* or sugar* or sweet* or food
or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohydrate*)).tw.
36. “HED calori*”.tw.
37. “HED-calori*”.tw.
38. “highcalori* food*”.tw.
39. “high calori* food*”.tw.
40. “high-calori* food*”.tw.
41. “lowcalori* food*”.tw.
42. “low calori* food*”.tw.
43. “low-calori* food*”.tw.
44. “ice cream*”.tw.
45. “unhealthy food*”.tw.
46. bakery.tw.
47. biscuit*.tw.
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48. cacao.tw.
49. cake*.tw.
50. calorie*.tw.
51. candy.tw.
52. candies.tw.
53. bonbon*.tw.
54. chocolate*.tw.
55. confectionar*.tw.
56. cookie*.tw.
57. isoglucose.tw.
58. jam.tw.
59. jelly.tw.
60. jellies.tw.
61. liquorice.tw.
62. macronutrient*.tw.
63. maltose.tw.
64. marmalade.tw.
65. marzipan.tw.
66. pastr*.tw.
67. sucrose.tw.
68. sugar.tw.
69. sugars.tw.
70. sugary.tw.
71. sweet*.tw.
72. exp Butter/
73. exp Dietary Fats/
74. exp Energy Intake/
75. exp Fast Foods/
76. exp Margarine/
77. exp Plant Oils/ec [Economics]
78. “fastfood*”.tw.
79. “fast food*”.tw.
80. “fast-food*”.tw.
81. “fattening-food*”.tw.
82. “fattening food*”.tw.
83. “fried food*”.tw.
84. (coconut OR cooking OR palmOR vegetable OR soya OR soybean OR rapeseedOR linseed OR sunflower OR sesame OR peanut
OR groundnut OR copra OR babassu OR olive OR thistle ADJ Oil).tw.
85. “salty-snack*”.tw.
86. “salty snack*”.tw.
87. “snack food*”.tw.
88. “snack-food*”.tw.
89. “takeaway food*”.tw.
90. “takeaway-food*”.tw.
91. “take away food*”.tw.
92. “take away-food*”.tw.
93. “take-away food*”.tw.
94. “take-away-food*”.tw.
95. “whole milk”.tw.
96. burger*.tw.
97. butter.tw.
98. cheese.tw.
99. cream.tw.
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100. crisps.tw.
101. (egg AND (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohy-
drate*)).tw.
102. (eggs AND (fat* or sugar* or sweet* or food or diet* or nutrition or overweight or drink* or beverage* or protein* or carbohy-
drate*)).tw.
103. (fat AND (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
104. (fatty AND (Food* or diet* or nutrition or nutrient or eat* or meal* or oil* or carbohydrate* or protein* or obesity or obese)).tw.
105. fats.tw.
106. fattening.tw.
107. fries.tw.
108. ghee.tw.
109. lard.tw.
110. margarine.tw.
111. mono-unsat*.tw.
112. monounsat*.tw.
113. omega3.tw.
114. “omega 3”.tw.
115. omega-3.tw.
116. pizza.tw.
117. polyunsat*.tw.
118. poly-unsat*.tw.
119. sausage*.tw.
120. suet.tw.
121. exp Carbonated Beverages/
122. exp Food Preferences/
123. exp Food Habits/
124. “caloric-drink*”.tw.
125. “caloric drink*”.tw.
126. “carbonated-beverage*”.tw.
127. “carbonated beverage*”.tw.
128. “carbonated-drink*”.tw.
129. “carbonated drink*”.tw.
130. “energy-drink*”.tw.
131. “energy drink*”.tw.
132. “fizzy-drink*”.tw.
133. “fizzy drink*”.tw.
134. “high-calori* drink*”.tw.
135. “high calori* drink*”.tw.
136. “soda pop”.tw.
137. “soft-drink*”.tw.
138. “soft drink*”.tw.
139. “sport-drink*”.tw.
140. “sport* drink*”.tw.
141. “sport*-drink*”.tw.
142. cola.tw.
143. soda.tw.
144. SSB*.tw.
145. syrup*.tw.
146. OR/30-145
147. 29 AND 146
148. (animals NOT (humans AND animals)).sh.
149. 147 NOT 148
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